At a glance
ClinicalIndex Comparison RecordN/ACompleted· 37 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Urinary AQP2 Excretion in Hypercholesterolemic Patients as a Measure of Effect of Statin Therapy
In Brief
An observational study for Hypercholesterolemia and Diabetes Insipidus. Completed, enrolled 37 participants across 1 site.
Detailed Summary
The purpose of this study is to test the hypothesis that the function and/or regulation of urinary aquaporin 2 in hypercholesterolemic humans is affected by standard statin therapy, as compared with diet alone
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypercholesterolemia, Diabetes Insipidus
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartOct 2013
Primary CompletionMay 2014
Study CompletionJul 2015
First PostedAug 2015
TodayJul 2026
First PostedAug 14, 2015
Enrollment StartOct 1, 2013
Primary CompletionMay 1, 2014
Study CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 10.9 years ago